Tumor Markers: A Guide to Laboratory Testing
Tumor markers are substances that can be measured in blood, urine, or tissue and may be elevated in some people with cancer. They are useful tools in specific situations, but they are not stand-alone cancer tests. This guide explains how tumor marker testing works, where it fits in care, and the limits of what a result can mean.
Key takeaways
- Tumor markers are substances produced by cancer cells or by normal cells in response to cancer, and they can be measured in blood, urine, or tissue.
- A single tumor marker result cannot diagnose or rule out cancer; many non-cancerous conditions can raise marker levels.
- Tumor markers are most often used to monitor a known cancer, assess response to treatment, or watch for recurrence after treatment.
- Some markers are used for screening only in specific high-risk groups, and only alongside other tests and clinical judgment.
- Results are interpreted with your history, physical exam, imaging, and sometimes biopsy findings, not in isolation.
- Not all cancers have a reliable marker, and a normal marker level does not guarantee that cancer is absent.
What Tumor Markers Are and How They Are Measured
Tumor markers are molecules that can be detected in body fluids or tissue. Some are produced directly by cancer cells, while others are made by normal cells in response to a cancer or to other conditions. Because of this, a marker is rarely specific to one disease. Common examples include proteins, hormones, enzymes, and genetic material, and they may be measured in a blood sample, a urine sample, or a piece of tissue removed during a biopsy.
Testing is usually done with a blood draw in an outpatient setting. The laboratory uses an assay, such as an immunoassay, to measure the amount of the marker present. Results are reported as a number, often with a reference range that varies by laboratory, assay method, and the person's age or sex. Because reference ranges differ between labs, comparing results from different laboratories or tracking a single value without context can be misleading.
How Tumor Markers Are Used in Clinical Care
Tumor markers are most valuable when they are used for a defined purpose in a person with a known or suspected diagnosis. They may be checked before treatment to establish a baseline, during treatment to see whether levels are falling, and after treatment to look for a rise that could suggest recurrence. In some cancers, marker levels correlate well with disease activity, so they can add useful information to imaging and clinical exams.
Markers are also used in a few screening or risk-assessment settings, but usually only for people at elevated risk and always in combination with other tests. For example, a marker may be part of a monitoring plan for someone with a strong family history or a known genetic predisposition, as determined by a clinician. Outside these specific situations, using markers to screen the general population is not recommended because false positives and false negatives are common.
Why a High or Normal Result Is Not a Diagnosis
A high tumor marker level does not by itself mean a person has cancer. Many benign conditions, including inflammation, infection, liver disease, kidney disease, and benign growths, can raise marker levels. Likewise, a normal level does not rule out cancer, because some tumors do not produce the marker being measured, or they produce too little to be detected. This is why a marker result is interpreted alongside imaging, biopsy, and the full clinical picture.
When a marker is elevated, a clinician may repeat the test to check for a trend, order imaging, or recommend a biopsy to examine tissue directly. A biopsy remains the standard way to confirm a cancer diagnosis. Marker tests are best understood as pieces of a larger assessment rather than as a yes-or-no answer, and their meaning depends heavily on why the test was ordered and what else is known about the person's health.
Limitations, Variability, and Questions to Ask
Tumor marker results can vary for reasons unrelated to cancer. Assay methods differ between laboratories, levels can fluctuate over time, and some markers rise with age or with common medications and health conditions. A result that is slightly outside a reference range may not be clinically meaningful, while a result within range may still require follow-up if symptoms or imaging are concerning. Trends over time are often more informative than a single value.
If you are offered tumor marker testing, it is reasonable to ask why the test is being done, how the result will change your care, and what the limitations are for your situation. Ask whether the same laboratory and assay will be used for repeat tests so results can be compared reliably. Understanding the purpose of the test helps you and your clinician use the information appropriately rather than reacting to a number without context.
Frequently Asked Questions
Can a tumor marker test diagnose cancer on its own?
No. Tumor marker tests cannot confirm or exclude cancer by themselves. Diagnosis generally requires a biopsy and examination of tissue, along with imaging and clinical evaluation. Marker results are used as supporting information.
Why might a tumor marker be elevated in someone without cancer?
Many non-cancerous conditions, such as inflammation, infection, liver or kidney disease, and benign growths, can raise marker levels. This is one reason marker tests are not used alone to screen the general population.
Does a normal tumor marker level mean there is no cancer?
Not necessarily. Some tumors do not produce the marker being measured, or they produce amounts too low to detect. A normal result does not rule out cancer, and it should be interpreted with other tests and clinical findings.
How often should tumor markers be checked?
There is no single schedule that applies to everyone. The frequency depends on the type of cancer, the purpose of testing, and the treatment plan. Your clinician will determine an appropriate interval based on your individual situation.
Sources
Ready to get tested? Examine the included markers, read the collection notes, and reserve the panel with the LabTestingClinic partner today.
Order Alpha-Fetoprotein (AFP) Tumor Marker TestReviewed by the LabTestingClinic Editorial Team
The LabTestingClinic editorial team reviews laboratory panels against published reference material before publication.